The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Eli Lilly and Company NYSE: LLY and Novo Nordisk A/S NYSE: NVO are two weight-loss and diabetes drug stocks that have been on completely different trajectories. Since the start of 2025, LLY is up near
Early data from weight-loss pills are lifting shares in Novo Nordisk and Eli Lilly as investors bet that easier-to-take drugs could expand the ​market to millions more patients and help counter pric

My Top Obesity Stock to Buy and Hold

04:45am, Thursday, 07'th May 2026
Eli Lilly's Zepbound is already generating billions of dollars in revenue, making it the clear leader in a rapidly expanding market. Lilly's ability to produce and deliver creates a hurdle that smalle
Eli Lilly And Co (NYSE:LLY) has capitalized on last week's impressive first-quarter earnings report.
Lilly surges after a Q1 beat and higher guidance, as Mounjaro and Zepbound fueled 56% revenue growth.
The S&P 500 has gained 5% this year, but there's the risk of a crash later in the year.
Eli Lilly ​said on ‌Wednesday it would ​commit ​an additional $4.5 billion ⁠investment across ​two ​of its three sites in ​Indiana, ​bringing the company's ‌total ⁠capital expans
Lilly's capital commitments to expand manufacturing in its home state now total $21 billion since 2020 Lilly Lebanon Advanced Therapies opens as company's first dedicated genetic medicine manufacturin
Novo Nordisk stock rose as it raised its guidance on the back of the strong performance of its weight-loss pill.
Eli Lilly (NYSE:LLY | LLY Price Prediction) received another bullish call from Wall Street.
In LUCENT-3, more than 60% of patients who achieved disease clearance at one year maintained it after four years of continuous Omvoh treatment Disease clearance is a high clinical bar in UC requiring
Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the strongest first quarters in big pharma history, but shares have pulled back sharply from their February peak.
AbbVie ABBV stock has risen around 5% since it announced robust first-quarter 2026 results on April 29. It beat estimates for both earnings and sales and the guidance for 2026 revenues and earnings w

Lilly declares second-quarter 2026 dividend

11:11am, Monday, 04'th May 2026
INDIANAPOLIS, May 4, 2026 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2026 of $1.73 per share on outstanding common st
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE